, Volume 7, Issue 3, pp 277–284 | Cite as

Aiolos and Ikaros: Regulators of lymphocyte development, homeostasis and lymphoproliferation

  • C. Schmitt
  • C. Tonnelle
  • A. Dalloul
  • C. Chabannon
  • P. Debré
  • A. Rebollo


Aiolos and Ikaros encode hemopoietic-specific zinc finger transcription factors that are important regulators of lymphocyte differentiation. Aiolos and Ikaros play a critical role in regulating B and T cell development. Gene targeting studies in mice have shown that inactivation of Ikaros family proteins leads to a complete absence of T, B, NK and dendritic cells, whereas a reduction of Ikaros activity induce hyperproliferation and lymphomas. Aiolos knock-out mice have quantitatively normal lymphoid cells but have chronically activated B cells producing autoantibodies and develop lymphomas with increased frequency. These proteins are involved in the control of gene expression and, associated to nuclear complexes, participate in nucleosome remodeling. This protein family governs cell fate decisions and regulates homeostasis through complex isoforms expression and dimerization. Changes in this regulatory network may reflect differentiation and proliferation adjustments made in lymphoid progenitors and precursors. The direct involvement of aberrant Ikaros protein expression in human hematological oncogenesis, although suggested by several studies, remains to be settled at the genomic level. These points will be discussed in the present review.

Aiolos Ikaros homeostasis lymphoproliferation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hahm K, Cobb BS, McCarty AS, et al Helios, a T cell restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev 1998; 12: 782–796.Google Scholar
  2. 2.
    Honma Y, Kiyosawa H, Mori T, et al Eos: A novel member of the Ikaros gene family expressed predominantly in the developing nervous system. FEBS Lett 1999; 447: 76–84.Google Scholar
  3. 3.
    Perdomo J, Holmes M, Chong B, Crossley M Eos and Pegasus two members of the Ikaros family of proteins with distinct DNA binding activities. J Biol Chem 2000; 49: 38347–38354.Google Scholar
  4. 4.
    Koipally J, Georgopoulus K Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. J Biol Chem 2000; 275: 19594–19606.Google Scholar
  5. 5.
    Lo K, Landau NR, Smale ST LyF-1, a transcription regulator that interacts with a novel class of promoters for lymphocytespecific genes. Mol Cell Biol 1991; 11: 5229–5243.Google Scholar
  6. 6.
    Georgopoulos K, Moore DD, Derfler B Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 1992; 258: 808–812.Google Scholar
  7. 7.
    Georgopoulos K, Bigby M, Wang J, et al The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994; 79: 143–156.Google Scholar
  8. 8.
    Wang H, Nichogiannopoulou A, Wu L, et al Selective defects in the development of the fetal and adult lymphoid system in mice with Ikaros null mutation. Immunity 1996; 5: 537–549.Google Scholar
  9. 9.
    Georgopoulos K, Winandy S, Avitahl N The role of the Ikaros gene in lymphocyte development and homeostasis. Annu Rev Immunol 1997; 15: 155–176.Google Scholar
  10. 10.
    Gally A, Christopherson I, Ferlazzo G, Liu G, Spits H, Georgopoulos K Distinct signals control the hematopoiesis of lymphoid-related dendritic cells. Blood 2000; 95: 128–136.Google Scholar
  11. 11.
    Tonnelle C, Bardin F, Maroc C, et al Forced expression of Ikaros6 isoform in human placental blood CD34+cells impairs their ability to differentiate toward the B lymphoid lineage. Blood 2001; 98: 2673–2680.Google Scholar
  12. 12.
    Morgan B, Sun L, Avitahl N, et al Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J 1997; 16: 2004–2013.Google Scholar
  13. 13.
    Hosokawa Y, Maeda Y, Takanashi E, Suzuki M, Seto M Human Aiolos, an Ikaros-related zinc finger DNA binding protein: cDNA cloning, tissue expression pattern and chromosomal mapping. Genomics 1999; 61: 326–329.Google Scholar
  14. 14.
    Wang J, Avitahl N, Cariappa A, et al Aiolos regulates B cell activation and maturation to effector state. Immunity 1998; 9: 543–553.Google Scholar
  15. 15.
    Cariappa A, Tang M, Parng C, et al The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk and CD21. Immunity 2001; 14: 603–615.Google Scholar
  16. 16.
    Liipo J, Nera K, Veisten E, et al Both normal and leukemic B lymphocytes express multiple isoforms of the hyman Aiolos gene. Eur J Immunol 2001; 31: 3469–3474.Google Scholar
  17. 17.
    Romero F, Martinez-A C, Camonis J, Rebollo A Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization. EMBO J 1999; 18: 3419–3430.Google Scholar
  18. 18.
    Rebollo A, Ayllon V, Fleischer A, Martinez-A C, Zaballos A The association of Aiolos transcription factor and Bcl-x is involved in the control of apoptosis. J Immunol 2001; 167: 6366–6373.Google Scholar
  19. 19.
    Liippo J, Mansikka A, Lassila O The evolutionary conserved avian Aiolos gene encodes alternative isoforms. Eur J Immunol 1999; 29: 2651–2657.Google Scholar
  20. 20.
    Hansen JD, Strassburger P, Pasquierm L Conservation of a master hematopoietic switch gene during vertebrate evolution: Isolation and characterization of Ikaros from teleost and amphibian species. Eur J Immunol 1997; 27: 3049–3058.Google Scholar
  21. 21.
    Haire R, Miracle A, Rast JP, Litman GW Members of the Ikaros gene family are present in early representative vertebrates. J Immunol 2000; 165: 306–312.Google Scholar
  22. 22.
    Cortes M, Wong E, Kiopally J, Georgopoulus K Control of lymphocyte development by the Ikaros gene family. Curr Opin Immunol 1999; 11: 167–171.Google Scholar
  23. 23.
    Sabbattini P, Lundgren M, Georgiou A, Chow C, Warner G, Dillon N Binding of Ikaros to the λ5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J 2001; 20: 2812–2822.Google Scholar
  24. 24.
    Koipally J, Renold A, Kim J, Georgopoulus K Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J 1999; 18: 3090–3100.Google Scholar
  25. 25.
    Brown K, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fleischer AG Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 1997; 91: 845–854.Google Scholar
  26. 26.
    Cockell M, Gasser S Nuclear compartments and gene regulation. Curr Opin Gent Dev 1999; 9: 199–207.Google Scholar
  27. 27.
    Cobb BS, Morales S, Kleiger G, Brown KE, Fischer AG, Smale ST Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev 2000; 14: 2146–2157.Google Scholar
  28. 28.
    Struhl K Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 1998; 12: 599–606.Google Scholar
  29. 29.
    Zhao K, Wang W, Rando O, et al Rapid and phosphoinositoldependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 1998; 95: 625–636.Google Scholar
  30. 30.
    Kuo MH, Allis CD Role of histone acetyltransferases and deacetylases in gene regulatin. BioEssay 1998; 20: 615–626.Google Scholar
  31. 31.
    Grunstein M Histone acetylation in chromatin structure and transcription. Nature 1997; 389: 349–352.Google Scholar
  32. 32.
    Kim J, Sif S, Jones B, et al Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 1999; 10: 345–355.Google Scholar
  33. 33.
    Klug CA, Morrison SA, Masek M, Hahm K, Smale ST, Weissman IL Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes. Proc Natl Acad Sci USA 1998, 95: 657–662.Google Scholar
  34. 34.
    Avitahl N, Winandy N, Friedrich C, Jones B, Ge Y, Georgopoulos K Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity 1999; 10: 333–343.Google Scholar
  35. 35.
    Clevers HC, Lomberg N, Dunlap S, Lacey E, Terhorst C An enhanced located in a CpG-island 3' to the TRC/CD3 epsilon gene confers T lymphocyte-specificity to its promoter. EMBO J 1989; 8: 2527–2535.Google Scholar
  36. 36.
    Duran DB, Shaw JP, Bushm MR, Replogle RE, Belagaje R, Crabtree GR Characterization of antigen receptor response elements within the IL-2 enhancer. Mol Cell Biol 1988; 8: 1715–1724.Google Scholar
  37. 37.
    Georgopoulos K, Bier E, Maxam A, Therhorst C A T cellspecific enhancer is located in a DNase I-hypersensitive area at the 3' end of the CD3-delta gene. EMBOJ 1998; 7: 2401–2408.Google Scholar
  38. 38.
    Gottschalk LR, Leiden JM Identification and functional characterization of the human T-cell receptor beta gene transcriptional enhancer: Common nuclear proteins interact with the transcriptional regulatory elements of the T-cell receptor alpha and beta genes. Mol Cell Biol 1990; 10: 5486–5495.Google Scholar
  39. 39.
    Hagman J, Travis A, Grosschedl R A novel lineage-specific nuclear factor regulates mb-1 gene transcription at the early stage of B cell differentiation. EMBO J 1991; 10: 3409–3417.Google Scholar
  40. 40.
    Ho IC, Leiden JM Regulation of human T-cell receptor alpha gene enhancer: Multiple ubiquitous and T-cell-specific nuclear proteins interact with four hypomethylated enhancer elements. Mol Cell Biol 1990; 10: 4720–4727.Google Scholar
  41. 41.
    Redondo JM, Hata S, Brocklehurts C, Krangel MS T cell specific transcriptional enhancer within the human T cell receptor and locus. Sicence 1990; 247: 1225.Google Scholar
  42. 42.
    Serfling E, Barthelmans R, Pfeuffer I, et al Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse IL-2 gene in T lymphocytes. EMBO J 1989; 8: 465–473.Google Scholar
  43. 43.
    Thompson CB, Wang CY, Ho IC, et al cis-Acting sequences required for inducible IL-2 enhancer function bind a novel Etsrelated protein, Elf-1. Mol Cell Biol 1992; 12: 1043–1053.Google Scholar
  44. 44.
    Winandy S, Wu P, Georgopoulus K A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 1995; 83: 289–299.Google Scholar
  45. 45.
    Molnar A, Wu P, Largespada DA, et al The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins highly conserved in human and mouse. J Immunol 1996; 156: 585–596.Google Scholar
  46. 46.
    Nakayama H, Ishimura F, Avitahl N, et al Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res 1999; 59: 3931–3934.Google Scholar
  47. 47.
    Olivero S, Marocm C, Beillardm E, et al Detection of different Ikaros isoforms in human leukemias using real-time quantitative polymerase chain reaction. Brit J Hematol 2000; 110: 826–830.Google Scholar
  48. 48.
    Nakase K, Ishimura F, Avitahl N, et al Dominant negative isoform of the Ikaros gene in patients with adult B cell acute lymphoblastic leukemia. Cancer Res 2000; 60: 4062–4065.Google Scholar
  49. 49.
    Sun L, Crotty M, Sensel M, et al Expression of dominant negative Ikaros isoforms in T cell acute lymphoblastic leukemia. Clin Can Res 1999; 5: 2112–2120.Google Scholar
  50. 50.
    Sun L, Heerema N, Crotty L, et al Expression of dominant negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1999; 96: 680–685.Google Scholar
  51. 51.
    Payne KJ, Nicolas J, Zhu JH, Barshy LW, Crooks GM Predominant expression of a novel Ikaros isoform in normal human hemopoiesis. J Immunol 2001; 167: 1867–1870.Google Scholar
  52. 52.
    Nakayama H, Ishimura F, Katayama Y, et al Ikaros expression in human hematopoietic lineages. Exp Hematol 2000; 28: 1232–1239.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • C. Schmitt
    • 1
  • C. Tonnelle
    • 2
  • A. Dalloul
    • 1
  • C. Chabannon
    • 2
  • P. Debré
    • 1
  • A. Rebollo
    • 3
  1. 1.Hôpital Pitié-Salpetrière U543, Bâtiment CERVIParis Cedex 13France
  2. 2.Institut Paoli-Calmettes, Centre Régional de Lutte Contre le Cancer Provence-Alpes-Côte d'AzurMarseilleFrance
  3. 3.Centro Nacional de BiotecnologíaMadridSpain

Personalised recommendations